FRI0164 DIFFERENCES BETWEEN RA PATIENTS WITH AND WITHOUT

ILD FROM A UNITED STATES TERTIARY REFERRAL CENTER
Objectives: To describe the characteristics of RA patients with and without ILD and to determine if medication use constitutes a risk factor for the development of ILD. Methods: The medical records of RA patients with and without ILD treated at one academic center between 2008 and 2016 were analyzed. Data extracted include: patient demographics, serology, medication use (prednisone, DMARDs, biologics or small molecule drugs), and self-reported disease activity as MDHAQ and RAPID 3 scores. The subtype of ILD was based upon HRCT imaging, and some patients through histology. Differences between RA-ILD patients and RA patients without ILD were determined by Fishers exact test, and t-tests with a p<0.05 were considered statistically significant. Results: The demographics and clinical data of 1,024 RA non-ILD patients and 96 RA-ILD patients indicate ILD patients were older males, had a higher mortality and were less likely to have been never smokers (Table 1) . At the onset of ILD diagnosis, 31% were on no medication, 56% on monotherapy (MTX 16%, prednisone 13%, Etanercept 7%, adalimumab or LEF 5%, Rituximab 4%, HCQ 3%, and <1% on infliximab, SSZ or tofacitinib) and 11% received combination therapy. Twenty five percent of the RA-ILD patients developed ILD preceding or coinciding with the diagnosis of RA. After the onset of ILD those patients were more likely to receive prednisone and less likely to receive MTX than those without ILD (p<0.05). The predominant types of ILD were as follows: UIP 27%, NSIP 15%, NSIP vs UIP 14%, and unclassifiable 9%. Background: Lungs in Rheumatoid arthritis (RA) seem to play an important role, not only as an extra-articular manifestation but also as a site of initiation of the disease and activation for the immune response. B lymphocytes are thought to be involved in the pathophysiology of RA and interstitial lung disease (ILD). The encouraging results of the use of Anti-CD20 treatments to stabilize articular symptoms and lung involvement reinforce this theory. Serum Free immunoglobulin Light Chains (FLC) might represent, in this context, an interesting marker of B lymphocytes activation during this disease. Objectives: To determine the serum FLC levels in RA patients with and without ILD and to study their possible association with disease characteristics and activity. Methods: Fifteen RA patients with clinically symptomatic interstitial lung disease, confirmed by computed tomography (RA-ILD) (53.3% females; mean age 61,27±6,48 years) and age matched RA patients (66.7% females) with no clinically evident interstitial disease (non-ILD) were studied. Clinical and immunological inflammatory characteristics were assessed for all the patients. FLC levels were quantified by turbidimetry (Freelite TM Kappa and Lambda Kits, The Binding Site, UK). Results: The mean serum FLC-κ levels (RA-ILD: 40,74±16,94 ng/ml vs non-ILD 24,88±8,87 ng/ml, p=0,003) and FLC-λ levels (RA-ILD: 37,34±16,56 ng/ml vs non-ILD 26,28±7,22 ng/ml, p=0,028) were significantly higher in patients with ILD compared to non-ILD, while the serum FLC-ratioκ/λ (RA-ILD: 1,15±0,38 vs non-ILD 1,00±0,43, p=0,304) were comparable. There was no significant difference for the DAS28 disease activity score between both groups (RA-ILD: 4,6±1,5 vs non-ILD 4, 38±1,46, p=0,69) . No significant correlations were found between the DAS28-score and FLCκ, FLCλ and FLCratioκ/λ (p>0,05). FLC-κ levels correlated significantly with ESR and CRP levels (p<0.001), FLC-λ levels with CRP (p=0,005) but not with ESR (p=0,247) and FLC-ratioκ/λ did not correlate with both ESR and CRP levels. Conclusions: High levels of serum FLC are associated with RA-ILD and with a higher degree of inflammation, supporting the role of B cell activation in the pathophysiology of RA with ILD. 
Background:
The relationship between mechanical stress and radiographic damage in rheumatoid arthritis (RA) has been detected in patients with hemiplegia 1) or poliomyelitis 2) . In patients without neurological disorder, Koh reported that radiographic damage was worse and progressed faster in the dominant hand in
